Esophageal Cancer Clinical Trials

Find Esophageal Cancer Clinical Trials Near You

Comparison of Efficacy and Safety of Different Analgesic Modes in Minimally Invasive Esophagectomy for Esophageal Cancer

Status: Recruiting
Location: See location...
Intervention Type: Drug, Device
Study Type: Interventional
Study Phase: Phase 2/Phase 3
SUMMARY

This study was designed to compare analgesic efficacy and safety of different perioperative analgesic modes in minimally invasive esophagectomy for esophageal cancer.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• 18-75 years;

• Patients underwent laparoscopic and thoracoscopic or robotic-assisted minimally invasive esophagectomy ;

• Informed consent.

Locations
Other Locations
China
Cancer Hospital Chinese Academy of Medical Sciences
RECRUITING
Beijing
Contact Information
Primary
zhu zhixiang
zhuzhixiang2010@163.com
13311131231
Time Frame
Start Date: 2022-10-10
Estimated Completion Date: 2025-12-20
Participants
Target number of participants: 102
Treatments
Other: Postoperative NSAIDs
Experimental: Preemptive analgesia followed by Postoperative NSAIDs
Experimental: Postoperative patient-controlled analgesia pump
Related Therapeutic Areas
Sponsors
Leads: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

This content was sourced from clinicaltrials.gov